The benefit of participating to clinical research

被引：0
|
作者：
N. Hébert-Croteau
J. Brisson
J. Lemaire
J. Latreille
机构：
[1] Institut National de Santé Publique du Québec,Direction des Systèmes de Soins et Services
[2] Hôpital Charles LeMoyne,Programme d’Oncologie
[3] Hôpital du Saint-Sacrement,Unité de Recherche en Santé des Populations
[4] Université de Sherbrooke,Département des Sciences Infirmières, Faculté de Médecine
来源：
Breast Cancer Research and Treatment | 2005年 / 91卷
关键词：
breast neoplasm; clinical trials; outcomes research; survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We assessed the impact of participating to clinical research among 1727 women with localized breast cancer. Using as referent individuals not treated according to guidelines for systemic therapy, the adjusted hazard ratio of death was 0.70 (95% confidence interval (CI): 0.54,0.90, p-value: 0.006) in those treated according to current guidelines and 0.45 (95% CI: 0.27,0.73, p-value: 0.001) in participants to research. Participation to clinical trials results in a substantial gain in survival.
引用
收藏
页码：279 / 281
页数：2
相关论文
共 50 条
12345